Clinical Trial Update: Alzheimer's Tau Platform: Master Protocol [Phase 2]

View source ↗

Summary

A Phase 2 master protocol trial evaluating an Alzheimer's tau platform across preclinical and prodromal Alzheimer's disease as well as Alzheimer's disease, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Alzheimer's Tau Platform

Snippet

Sponsor: Paul S. Aisen | Conditions: Preclinical Alzheimer's Disease, Alzheimer Disease | Phase 2 | Status: NOT_YET_RECRUITING